Skip to main content
OpenTrials
Completed

NCT Number: NCT05076110

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hip Arthroscopy

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Mayo clinic

Rochester, Minnesota, 55401, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)

Exclusion criteria

  • medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
  • Substantial alcohol or drug abuse.
  • History of narcotics within 6 months of surgery.
  • Pregnancy.
  • Renal impairment.
  • Peptic ulcer disease.
  • GI bleeding.

Treatment and study plan

Oxycodone

Drug

5 mg tablets every 4 hours postoperatively as needed for pain control

Ibuprofen

Drug

800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day

Gabapentin

Drug

300 mg three times a day for 5 days then wean off by day 10 postoperatively

Acetaminophen

Drug

1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day

Methocarbamol

Drug

500 mg three times a week for 2 weeks postoperatively

Other names: Robaxin

Primary outcomes

  1. Change in Pain Score

    Time frame: 1 day post-operatively, 14 days post-operatively

    The change in pain score measured using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain with higher scores indicating worsening pain.

Secondary outcomes

  1. Change in Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score

    Time frame: Baseline; 14 days post operatively

    The PROMIS Pain Interference Score is a 6-item patient-reported measure assessing how pain disrupts daily activities. Responses are scored on a 5-point Likert scale (1= Not at all to 5= very much). Each item is scored individually, and the raw scores are summed to produce a total score. The total raw score is then converted to a T-score which standardizes the score with a mean of 50 and a standard deviation of 10 based on the general population. Higher T-scores indicate greater interference.

  2. Change in Opioid Consumption

    Time frame: Day 1 Post-Operatively; Day 14 Post-Operatively

    The change in opioid consumption from day 1 post-operative to day 14 post-operative in the opioid arm expressed in morphine milligram equivalents (MME).

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Oct 13, 2021
Registry last updated
Jun 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.